A previous study has already reported a highly significant correlation between MASLD and the incidence of HCC, the progression of liver disease, and the risk of liver-related mortality ( 21 ).
← all excerpts
Impact of metabolic dysfunction-associated steatotic liver disease on long-term prognosis in hepatocellular carcinoma patients undergoing hepatectomy.
1
—
—